Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,459 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized controlled trial of surgery and postoperative modified FOLFOX6 versus surgery and perioperative modified FOLFOX6 plus cetuximab in patients with KRAS wild-type resectable colorectal liver metastases: EXPERT study.
Matsumura M, Hasegawa K, Oba M, Yamaguchi K, Uetake H, Yoshino T, Morita S, Takahashi K, Unno M, Shimada Y, Muro K, Matsuhashi N, Mori M, Baba H, Shimada M, Mise Y, Kawaguchi Y, Kagimura T, Ishigure K, Saiura A, Sugihara K, Kokudo N. Matsumura M, et al. Langenbecks Arch Surg. 2022 Jun;407(4):1345-1356. doi: 10.1007/s00423-022-02434-7. Epub 2022 Feb 25. Langenbecks Arch Surg. 2022. PMID: 35211831 Clinical Trial.
Pretreatment Positron Emission Tomography with 18F-Fluorodeoxyglucose May Be a Useful New Predictor of Early Progressive Disease following Atezolizumab plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma.
Kawamura Y, Kobayashi M, Shindoh J, Matsumura M, Okubo S, Muraishi N, Fujiyama S, Hosaka T, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Ikeda K, Arase Y, Hashimoto M, Kumada H. Kawamura Y, et al. Among authors: matsumura m. Oncology. 2022;100(6):320-330. doi: 10.1159/000523850. Epub 2022 Mar 1. Oncology. 2022. PMID: 35231914 Free PMC article.
The Impact of Lenvatinib on Tumor Blood Vessel Shrinkage of Hepatocellular Carcinoma during Treatment: An Imaging-Based Analysis.
Muraishi N, Kawamura Y, Akuta N, Shindoh J, Matsumura M, Okubo S, Fujiyama S, Hosaka T, Saitoh S, Sezaki H, Suzuki F, Suzuki Y, Ikeda K, Arase Y, Hashimoto M, Yasuda I, Kumada H. Muraishi N, et al. Among authors: matsumura m. Oncology. 2023;101(2):134-144. doi: 10.1159/000526976. Epub 2022 Sep 14. Oncology. 2023. PMID: 36103864 Free PMC article.
Well-preserved liver function enhances the clinical impact of curative-intent subsequent treatment during lenvatinib treatment for unresectable hepatocellular carcinoma.
Kawamura Y, Akuta N, Shindoh J, Matsumura M, Okubo S, Tominaga L, Fujiyama S, Hosaka T, Saitoh S, Sezaki H, Suzuki F, Suzuki Y, Ikeda K, Arase Y, Hashimoto M, Kozuka T, Kumada H. Kawamura Y, et al. Among authors: matsumura m. Clin J Gastroenterol. 2023 Feb;16(1):1-12. doi: 10.1007/s12328-022-01723-4. Epub 2022 Nov 7. Clin J Gastroenterol. 2023. PMID: 36344851
1,459 results